ADMA logo

ADMA
Adma Biologics Inc

20,404
Loading...
Loading...
News
all
press releases
Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True?
The average brokerage recommendation (ABR) for Adma Biologics (ADMA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Zacks·1d ago
News Placeholder
More News
News Placeholder
Adma Biologics (ADMA) Stock Moves -1.36%: What You Should Know
In the latest trading session, Adma Biologics (ADMA) closed at $14.54, marking a -1.36% move from the previous day.
Zacks·4d ago
News Placeholder
Why Adma Biologics (ADMA) Outpaced the Stock Market Today
Adma Biologics (ADMA) concluded the recent trading session at $15.05, signifying a +2.66% move from its prior day's close.
Zacks·13d ago
News Placeholder
Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views?
The average brokerage recommendation (ABR) for Adma Biologics (ADMA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Zacks·18d ago
News Placeholder
Adma Biologics (ADMA) Declines More Than Market: Some Information for Investors
In the latest trading session, Adma Biologics (ADMA) closed at $15.32, marking a -2.17% move from the previous day.
Zacks·19d ago
News Placeholder
Are Options Traders Betting on a Big Move in ADMA Biologics Stock?
Investors need to pay close attention to ADMA stock based on the movements in the options market lately.
Zacks·19d ago
News Placeholder
Adma Biologics (ADMA) Stock Dips While Market Gains: Key Facts
In the latest trading session, Adma Biologics (ADMA) closed at $15.91, marking a -1.55% move from the previous day.
Zacks·25d ago
News Placeholder
Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note
Adma Biologics (ADMA) closed the most recent trading day at $15.3, moving 5.03% from the previous trading session.
Zacks·29d ago
News Placeholder
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?
Based on the average brokerage recommendation (ABR), Adma Biologics (ADMA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Zacks·1mo ago
News Placeholder
ADMA Beats on Q2 Earnings and Revenues, Asceniv Drives Momentum
ADMA Biologics' Q2 earnings and revenue beat can be attributed to Asceniv growth. However, shares fall 7.4% in after-hours trading.
Zacks·2mo ago

Latest ADMA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.